Delivery Order SPE2D021DA002-SPE2D325F307L
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,969.50 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The delivery order covers ENGERIX-B 20 micrograms per milliliter in syringe format, a hepatitis B vaccine commonly administered to military personnel and federal healthcare...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,575.60 for ENGERIX-B 20 mcg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 17, 2025, will be performed at the awardee's Park Ridge location. The contract was awarded without a set-aside designation, and represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,090.20 for ENGERIX-B 20 MCG/ML vaccine syringes. The award, issued on August 6, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain program, which procures pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,878.00 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 8, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,757.30 on July 15, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. The award, which carries an ultimate completion date of July 18, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain function. This delivery order is issued under DMS...
- This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe vaccines in 0.5 milliliter quantities. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,971.76 by the Defense Logistics Agency for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract utilizes firm fixed-price pricing with an ultimate completion date of September 19, 2025, and was awarded on September 18, 2025, with no set-aside designation applied. The place of performance is Park...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,607.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS...
- This federal contract award, valued at $4,724.16, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to supply the Defense Department with ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F307LDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status. This award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent IDC, awarded under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for diverse medical products including vaccines, prescription medications, and specialty pharmaceuticals distributed to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/11/25 |